On June 1st, TIF representatives, Dr Androulla Eleftheriou and Dr Michael Angastiniotis and Mr Loris Brunetta, Board Member, had a fruitful discussion with patient advocates from the AMRO region about the pandemic’s situation reports and challenges related to individuals with thalassaemia in these areas.
Related Articles

TIF Webinar Fridays Are Back With A New Session on “Heart Disease In Thalassaemia”
20 Οκτωβρίου, 2020

Gene Therapy LentiGlobin Granted Priority Medicines Designation for Sickle Cell Disease in the EU
2 Οκτωβρίου, 2020
Check Also
Close
-
TIF Takes Active Part At The IAPO 9th Global Patients Congress
29 Σεπτεμβρίου, 2020